» Articles » PMID: 10352166

Use of Alternative Medicine by Women with Early-stage Breast Cancer

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1999 Jun 3
PMID 10352166
Citations 136
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We analyzed the use of alternative medicine by women who had received standard therapy for early-stage breast cancer diagnosed between September 1993 and September 1995.

Methods: A cohort of 480 patients with newly diagnosed early-stage breast cancer was recruited from a Massachusetts statewide cohort of women participating in a study of how women choose treatment for cancer. Alternative medical treatments, conventional therapies, and health-related quality of life were examined.

Results: New use of alternative medicine after surgery for breast cancer was common (reported by 28.1 percent of the women); such use was not associated with choices about standard medical therapies after we controlled for clinical and sociodemographic variables. A total of 10.6 percent of the women had used alternative medicine before they were given a diagnosis of breast cancer. Women who initiated the use of alternative medicine after surgery reported a worse quality of life than women who never used alternative medicine. Mental health scores were similar at base line among women who decided to use alternative medicine and those who did not, but three months after surgery the use of alternative medicine was independently associated with depression, fear of recurrence of cancer, lower scores for mental health and sexual satisfaction, and more physical symptoms as well as symptoms of greater intensity. All groups of women reported improving quality of life one year after surgery.

Conclusions: Among women with newly diagnosed early-stage breast cancer who had been treated with standard therapies, new use of alternative medicine was a marker of greater psychosocial distress and worse quality of life.

Citing Articles

Phyto-therapeutics as anti-cancer agents in breast cancer: Pathway targeting and mechanistic elucidation.

Almilaibary A Saudi J Biol Sci. 2024; 31(3):103935.

PMID: 38327657 PMC: 10847379. DOI: 10.1016/j.sjbs.2024.103935.


Optimization of cultural and nutritional conditions to enhance mycelial biomass of Cordyceps militaris using statistical approach.

Deshmukh N, Bhaskaran L Braz J Microbiol. 2023; 55(1):235-244.

PMID: 38150151 PMC: 10920581. DOI: 10.1007/s42770-023-01222-9.


Review on Natural Agents as Aromatase Inhibitors: Management of Breast Cancer.

Singh S Comb Chem High Throughput Screen. 2023; 27(18):2623-2638.

PMID: 37861041 DOI: 10.2174/0113862073269599231009115338.


: A Review on the Antiproliferative Potential in Breast Cancer Cells.

Moremane M, Abrahams B, Tiloke C Curr Issues Mol Biol. 2023; 45(8):6880-6902.

PMID: 37623253 PMC: 10453312. DOI: 10.3390/cimb45080434.


The role of biofield energy treatment on psychological symptoms, mental health disorders, and stress-related quality of life in adult subjects: A randomized controlled clinical trial.

Trivedi M, Branton A, Trivedi D, Mondal S, Jana S J Gen Fam Med. 2023; 24(3):154-163.

PMID: 37261039 PMC: 10227731. DOI: 10.1002/jgf2.606.